- Unyango
- Ubungqina
- I-Neuroblastoma
- Ithumba Eliqinileyo
- Ubungqina
- Ii-TILS
- Unyango lweeSeli zeNK
- I-Myasthenia Gravis (MG)
- I-Acute Lymphoblastic Leukemia (B-ALL)
- I-Systemic Lupus Erythematosus (SLE)
- I-Acute Lymphoblastic Leukemia (T-ALL)
- I-NonHodgkin Lymphoma (NHL)
- I-Multiple Myeloma(MM)
- Ukusasaza i-B-cell Lymphom enkulu
- I-B-lymphocytic Leukemia
- I-Myeloma
I-Acute Lymphoblastic Leukemia (T-ALL)-06
Isigulana sabantwana esineminyaka emi-2 ubudala esine-T-ALL sifumana ukuphumla emva konyango lwe-CAR-T emva kokufumana i-chemotherapy enzulu izihlandlo ezingaphezu kweshumi.
UXiaohong oneminyaka emibini ubudala waseZhejiang wafunyaniswa ene-leukemia ehlotyeni elidlulileyo. Emva konyango olungaphezu konyaka, i-flow cytometry yafumanisa ukuba isifo siphinde sabuyela esiqhelweni, nto leyo eyakhokelela ekubeni usapho lufune unyango lwe-CAR-T immunotherapy kwi-BIOOCUS Medical Group.
Ngomhla wesi-9 kweyeThupha, ngowama-2020, uXiaohong wangeniswa kwisibhedlele sabantwana sasekuhlaleni ngenxa "yomkhuhlane weentsuku ezintathu." Uvavanyo lwe-MICM yomongo lwafumanisa ukuba une-acute lymphoblastic leukemia (T-ALL). Emva kwekhosi enye ye-chemotherapy, i-bone marrow morphology yabonisa ukuxolelwa okupheleleyo, kwaye i-flow cytometry ayizange ifumane iiseli ezinobungozi ezingavuthwanga. I-chemotherapy enzulu eyalandelayo kwiikhosi ezili-11 yagcina ukuxolelwa okupheleleyo komongo wethambo.
Ngomhla wesi-3 kuSeptemba 2021, ukugqobhozwa komnkantsha wethambo okulandelayo kwabonisa ukuxolelwa ngokupheleleyo kwimo yeseli, kodwa i-flow cytometry yabonisa iiseli ezingavuthwanga eziyi-1.85%. Efuna unyango olongezelelweyo, uXiaohong wangeniswa kwiziko lethu le-CGT ngomhla wama-24 kuSeptemba. Emva kokungeniswa, imo yemnkantsha wethambo yayisekwimo yemnkantsha epheleleyo, kodwa i-immunophenotyping yabonisa ukuba ii-lymphocytes ze-T ezingavuthwanga ziyi-0.10%.
Ngenxa yokuba uXiaohong wayesemncinci kwaye esi sifo siqhubeke ixesha elide nangona wayefumana unyango oluqatha lwe-chemotherapy, iqela lezonyango kwicandelo lesibini le-hematology lagqiba kwelokuba uXiaohong angabhalisa kuvavanyo lweklinikhi lwe-CD7 CAR-T.
Ngomhla wama-30 kuSeptemba, ngo-2021, kwaqokelelwa iiseli zegazi ezingaphandle ukuze kukhuliswe iiseli ze-CAR-T. Ngomhla we-10 kuOkthobha, uXiaohong wafumana i-FC regimen chemotherapy. Ngomhla we-13 kuOkthobha, ukubhobozwa kwethambo lomongo kwabonisa ukuqhuma okungaphantsi kwe-5% kwi-morphology, kwaye i-flow cytometry yabonisa iiseli ze-T ezingekavuthwa ezingama-0.37%. Ngomhla we-15 kuOkthobha, iiseli ze-CD7 CAR-T zaphinda zafakwa.
Ngomhla wesi-3 kweyoMqungu (iintsuku ezingama-20 emva kokufakelwa kwakhona), ukubhobozwa komongo wethambo kwabonisa ukuxolelwa ngokupheleleyo kwimo yeseli, kungekho ziseli zingavuthwanga ezifunyenweyo yi-flow cytometry. Imeko kaXiaohong izinzile ukususela ngoko, kwaye udluliselwe kwicandelo lokufakelwa ukuze alungiselele ukufakelwa kweseli ye-hematopoietic stem.
UXiaohong wayengaphantsi konyaka ubudala xa wagula waza wanyamezela unyango lwamayeza unyaka wonke. Ukuphumelela ekutshintsheni iseli emva konyango lwe-CD7 CAR-T kuye kwanika isixhobo esinamandla sokuphelisa ngokupheleleyo esi sifo.
inkcazo2
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

